Guru Ownership Trend
Guru Analysis for Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. (ALNY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $221.29 M.
Top institutional holders include Cliff Asness and Ray Dalio.
Institutional sentiment is currently Bearish. This is evidenced by a $59.29 M net outflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 3.4%. Conversely, Cliff Asness reduced exposure by 20.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Alnylam Pharmaceuticals, Inc. (ALNY)
Major holders include Cliff Asness ($218.99 M), Ray Dalio ($29.98 M), Joel Greenblatt ($12.66 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 900,189 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $59.29 M, with 1 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 5 managers trimmed their positions, while 0 fully exited ALNY. The total reported sell value was $59.35 M.
Yes, 0 managers opened new positions in ALNY, and 1 increased their existing holdings. The total reported buy value was $62,315.84.